Uncomplicated urinary tract infections: Impact of increasing antibiotic resistance in the community;Traitement des infections urinaires simples: Impact des résistances antibiotiques croissantes dans la communauté

Revue Medicale Suisse

Volumn 8, Issue 338, 2012, Pages 878-881

  Clerc, O ^a   Prod'Hom, G ^a   Petignat, C ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; COMMUNITY; EMPIRICAL RESEARCH; HUMAN; PATHOGENESIS; REVIEW; URINARY TRACT INFECTION; BIOTA; CLINICAL PRACTICE; INTERNAL MEDICINE; METAGENOME; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PYELONEPHRITIS; STATISTICS;

ANTI-BACTERIAL AGENTS; BIOTA; DRUG RESISTANCE, MICROBIAL; HUMANS; INTERNAL MEDICINE; METAGENOME; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PYELONEPHRITIS; URINARY TRACT INFECTIONS;

EID: 84862733974     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003;17:303-32. (Pubitemid 36760185)
2. **Bally F, Troillet N. Urinary tract infection : A tailored diagnosis. Rev Med Suisse 2008;4:2145-8.
3. Fihn SD. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003;349: 259-66. (Pubitemid 36859478)
4. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis : A meta-analysis of randomized controlled trials. J Infect 2009;58:91-102.
5. Foxman B. Recurring urinary tract infection : Incidence and risk factors. Am J Public Health 1990;80:331-3. (Pubitemid 20080925)
6. **Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women : A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-20.
7. Naber KG, Wullt B, Wagenlehner FM. Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women. Int J Antimicrob Agents 2011; 38:21-35.
8. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005;71:933-42. (Pubitemid 40321958)
9. *Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection ? JAMA 2002;287:2701-10. (Pubitemid 34533549)
10. Lamoth F, Wenger A, Prod'hom G, et al. Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection. Infection 2010;38:249-53.
11. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC) : Implications for empiric therapy. Eur Urol 2008;54:1164-75.
12. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 2003;22: 49-52.
13. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates : Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.
14. Johnson L, Sabel A, Burman WJ, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008;121:876-84.
15. Pitoud LD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae : An emerging public-health concern. Lancet Infect Dis 2008;8:159-66. (Pubitemid 351249250)
16. Doi Y, Paterson DL, Egea P, et al. Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010; 16:33-8.
17. Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum b-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections : An increasing challenge for antimicrobial therapy. Infection 2011;39:333-40.
18. Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum betalactamases. Expert Rev Anti Infect Ther 2008;6:671-83.
19. **Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010;7:653-60.
20. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001;1:101-14. (Pubitemid 33586045)
21. Fantin B, Duval X, Massias L, et al. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J Infect Dis 2009;200:390-8.
22. Knothe H, Schäfer V, Sammann A, Shah PM. Influence of fosfomycin on the intestinal and pharyngeal flora of man. Infection 1991;19:18-20.
23. Raz R. Fosfomycin : An old-new antibiotic. Clin Microbiol Infect 2012;18:4-7.
24. Karageorgopoulos DE, Wang R, Yu XH, Falagas ME. Fosfomycin : Evaluation of the published evidence on the emergence of antimicrobial resistance in Gramnegative pathogens. J Antimicrob Chemother 2012;67: 255-68.
25. Kashanian J, Hakimian P, Blute M, et al. Nitrofurantoin : The return of an old friend in the wake of growing resistance. BJU Int 2008;102:1634-7.
26. Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001; 61:353-64. (Pubitemid 32270044)
27. Gilbert DN. Urinary tract infections in patients with chronic renal insufficiency. Clin J Am Soc Nephrol 2006; 1:327-31.
28. Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002;34:1061-6. (Pubitemid 34289678)